Please enable JavaScript to continue using this application.

Compare $EXOZ vs $HRGN | Chartloom

Compare

$EXOZ vs $HRGN

eXoZymes Inc · Harvard Apparatus Regenerative Technology Inc

EXOZ

eXoZymes Inc

HRGN

Harvard Apparatus Regenerative Technology Inc

Compare $EXOZ vs $HRGN

Comparing eXoZymes Inc and Harvard Apparatus Regenerative Technology Inc

EXOZeXoZymes Inc

HRGNHarvard Apparatus Regenerative Technology Inc

EXOZeXoZymes Inc

Market cap

$49M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-52.2%

52W performance

-66.1%

FCF yield

-14.7%

HRGNHarvard Apparatus Regenerative Technology Inc

Market cap

$40M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

44.6%

YTD performance

16.2%

52W performance

-15.8%

FCF yield

-9.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

EXOZ

HRGN

Detailed metrics comparison

EXOZ

eXoZymes Inc

HRGN

Harvard Apparatus Regenerative Technology Inc

Market Cap

EXOZ$49M

HRGN$40M

Enterprise Value

EXOZ$43M

HRGN$41M

Price

EXOZ$5.25

HRGN$2.30

P/E Ratio

EXOZN/A

HRGNN/A

P/S Ratio

EXOZ0.00x

HRGN41.18x

EV/Sales

EXOZ0.00x

HRGN41.33x

EV/EBITDA

EXOZ0.00x

HRGN0.00x

P/B Ratio

EXOZ14.66x

HRGN507.11x

P/FCF Ratio

EXOZN/A

HRGNN/A

EV/FCF

EXOZ-6.04x

HRGN-11.16x

PEG Ratio

EXOZN/A

HRGNN/A

Forward P/E (NTM)

EXOZN/A

HRGNN/A

Forward P/S (NTM)

EXOZN/A

HRGNN/A

Revenue (TTM)

EXOZ$0

HRGN$982K

Revenue Growth (YoY)

EXOZN/A

HRGN44.6%

Forward Rev Growth

EXOZ0.0%

HRGN0.0%

Gross Margin (TTM)

EXOZ0.0%

HRGN7.5%

Operating Margin (TTM)

EXOZ0.0%

HRGN0.0%

EBITDA Margin (TTM)

EXOZ0.0%

HRGN-682.9%

Net Margin (TTM)

EXOZ0.0%

HRGN-680.5%

FCF Margin (TTM)

EXOZN/A

HRGN-370.2%

Net Income (TTM)

EXOZ$-10M

HRGN$-7M

FCF (TTM)

EXOZ$-7M

HRGN$-4M

EPS (TTM)

EXOZ-$1.18

HRGN-$0.38

ROE (TTM)

EXOZ-29213.0%

HRGN-78637.0%

ROA (TTM)

EXOZ-15866.0%

HRGN-30701.0%

ROIC (TTM)

EXOZ-28374.0%

HRGN-77233.0%

Cash

EXOZ$6M

HRGN$351K

Debt

EXOZ$87K

HRGN$500K

Net Cash/Debt

EXOZ$6M

HRGN$-149K

Current Ratio (TTM)

EXOZ3.81x

HRGN0.26x

Quick Ratio (TTM)

EXOZ3.63x

HRGN0.12x

Debt/Equity (TTM)

EXOZ0.02x

HRGN0.00x

Debt/Assets (TTM)

EXOZ0.0%

HRGN0.0%

Interest Coverage (TTM)

EXOZN/A

HRGNN/A

Net Debt/EBITDA (TTM)

EXOZ0.00x

HRGN0.00x

Beta

EXOZ1.20

HRGN-0.50

52W Performance

EXOZ-66.1%

HRGN-15.8%

YTD Performance

EXOZ-52.2%

HRGN16.2%

% from 52W High

EXOZ-71.5%

HRGN-21.2%

% from 52W Low

EXOZ20.7%

HRGN145.8%

Asset Turnover (TTM)

EXOZ0.00x

HRGN0.45x

FCF Yield (TTM)

EXOZ-14.7%

HRGN-9.0%

Earnings Yield (TTM)

EXOZ-20.9%

HRGN-16.5%

Dividend Yield (TTM)

EXOZN/A

HRGNN/A

Rule of 40

EXOZ0.0

HRGN-325.5

EV/GP/RG

EXOZN/A

HRGNN/A

Ticker research

View EXOZ research View HRGN research

Metric	EXOZ eXoZymes Inc	HRGN Harvard Apparatus Regenerative Technology Inc
Market & Valuation
Market Cap	$49M	$40M
Enterprise Value	$43M	$41M
Price	$5.25	$2.30
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	41.18x
EV/Sales	0.00x	41.33x
EV/EBITDA	0.00x	0.00x
P/B Ratio	14.66x	507.11x
P/FCF Ratio	N/A	N/A
EV/FCF	-6.04x	-11.16x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$982K
Revenue Growth (YoY)	N/A	44.6%
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	7.5%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-682.9%
Net Margin (TTM)	0.0%	-680.5%
FCF Margin (TTM)	N/A	-370.2%
Net Income (TTM)	$-10M	$-7M
FCF (TTM)	$-7M	$-4M
EPS (TTM)	-$1.18	-$0.38
ROE (TTM)	-29213.0%	-78637.0%
ROA (TTM)	-15866.0%	-30701.0%
ROIC (TTM)	-28374.0%	-77233.0%
Financial Health
Cash	$6M	$351K
Debt	$87K	$500K
Net Cash/Debt	$6M	$-149K
Current Ratio (TTM)	3.81x	0.26x
Quick Ratio (TTM)	3.63x	0.12x
Debt/Equity (TTM)	0.02x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.20	-0.50
52W Performance	-66.1%	-15.8%
YTD Performance	-52.2%	16.2%
% from 52W High	-71.5%	-21.2%
% from 52W Low	20.7%	145.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.45x
FCF Yield (TTM)	-14.7%	-9.0%
Earnings Yield (TTM)	-20.9%	-16.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-325.5
EV/GP/RG	N/A	N/A
Ticker research	View EXOZ research	View HRGN research

Valuation

P/S Ratio

EXOZ

0.00x

HRGN

41.18x

EV/FCF

HRGN

-11.16x

EXOZ

-6.04x

Growth & revenue

Revenue Growth TTM

HRGN

44.6%

Forward Revenue Growth

EXOZ

0.0%

HRGN

0.0%

Profitability & performance

Gross Margin

HRGN

7.5%

EXOZ

0.0%

ROE

EXOZ

-29213.0%

HRGN

-78637.0%

FCF Yield %

HRGN

-9.0%

EXOZ

-14.7%

52-Week Performance

HRGN

-15.8%

EXOZ

-66.1%

Detailed metrics comparison

EXOZ

eXoZymes Inc

HRGN

Harvard Apparatus Regenerative Technology Inc

Market Cap

EXOZ$49M

HRGN$40M

Enterprise Value

EXOZ$43M

HRGN$41M

Price

EXOZ$5.25

HRGN$2.30

P/E Ratio

EXOZN/A

HRGNN/A

P/S Ratio

EXOZ0.00x

HRGN41.18x

EV/Sales

EXOZ0.00x

HRGN41.33x

EV/EBITDA

EXOZ0.00x

HRGN0.00x

P/B Ratio

EXOZ14.66x

HRGN507.11x

P/FCF Ratio

EXOZN/A

HRGNN/A

EV/FCF

EXOZ-6.04x

HRGN-11.16x

PEG Ratio

EXOZN/A

HRGNN/A

Forward P/E (NTM)

EXOZN/A

HRGNN/A

Forward P/S (NTM)

EXOZN/A

HRGNN/A

Revenue (TTM)

EXOZ$0

HRGN$982K

Revenue Growth (YoY)

EXOZN/A

HRGN44.6%

Forward Rev Growth

EXOZ0.0%

HRGN0.0%

Gross Margin (TTM)

EXOZ0.0%

HRGN7.5%

Operating Margin (TTM)

EXOZ0.0%

HRGN0.0%

EBITDA Margin (TTM)

EXOZ0.0%

HRGN-682.9%

Net Margin (TTM)

EXOZ0.0%

HRGN-680.5%

FCF Margin (TTM)

EXOZN/A

HRGN-370.2%

Net Income (TTM)

EXOZ$-10M

HRGN$-7M

FCF (TTM)

EXOZ$-7M

HRGN$-4M

EPS (TTM)

EXOZ-$1.18

HRGN-$0.38

ROE (TTM)

EXOZ-29213.0%

HRGN-78637.0%

ROA (TTM)

EXOZ-15866.0%

HRGN-30701.0%

ROIC (TTM)

EXOZ-28374.0%

HRGN-77233.0%

Cash

EXOZ$6M

HRGN$351K

Debt

EXOZ$87K

HRGN$500K

Net Cash/Debt

EXOZ$6M

HRGN$-149K

Current Ratio (TTM)

EXOZ3.81x

HRGN0.26x

Quick Ratio (TTM)

EXOZ3.63x

HRGN0.12x

Debt/Equity (TTM)

EXOZ0.02x

HRGN0.00x

Debt/Assets (TTM)

EXOZ0.0%

HRGN0.0%

Interest Coverage (TTM)

EXOZN/A

HRGNN/A

Net Debt/EBITDA (TTM)

EXOZ0.00x

HRGN0.00x

Beta

EXOZ1.20

HRGN-0.50

52W Performance

EXOZ-66.1%

HRGN-15.8%

YTD Performance

EXOZ-52.2%

HRGN16.2%

% from 52W High

EXOZ-71.5%

HRGN-21.2%

% from 52W Low

EXOZ20.7%

HRGN145.8%

Asset Turnover (TTM)

EXOZ0.00x

HRGN0.45x

FCF Yield (TTM)

EXOZ-14.7%

HRGN-9.0%

Earnings Yield (TTM)

EXOZ-20.9%

HRGN-16.5%

Dividend Yield (TTM)

EXOZN/A

HRGNN/A

Rule of 40

EXOZ0.0

HRGN-325.5

EV/GP/RG

EXOZN/A

HRGNN/A

Ticker research

View EXOZ research View HRGN research

Metric	EXOZ eXoZymes Inc	HRGN Harvard Apparatus Regenerative Technology Inc
Market & Valuation
Market Cap	$49M	$40M
Enterprise Value	$43M	$41M
Price	$5.25	$2.30
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	41.18x
EV/Sales	0.00x	41.33x
EV/EBITDA	0.00x	0.00x
P/B Ratio	14.66x	507.11x
P/FCF Ratio	N/A	N/A
EV/FCF	-6.04x	-11.16x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$982K
Revenue Growth (YoY)	N/A	44.6%
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	7.5%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-682.9%
Net Margin (TTM)	0.0%	-680.5%
FCF Margin (TTM)	N/A	-370.2%
Net Income (TTM)	$-10M	$-7M
FCF (TTM)	$-7M	$-4M
EPS (TTM)	-$1.18	-$0.38
ROE (TTM)	-29213.0%	-78637.0%
ROA (TTM)	-15866.0%	-30701.0%
ROIC (TTM)	-28374.0%	-77233.0%
Financial Health
Cash	$6M	$351K
Debt	$87K	$500K
Net Cash/Debt	$6M	$-149K
Current Ratio (TTM)	3.81x	0.26x
Quick Ratio (TTM)	3.63x	0.12x
Debt/Equity (TTM)	0.02x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.20	-0.50
52W Performance	-66.1%	-15.8%
YTD Performance	-52.2%	16.2%
% from 52W High	-71.5%	-21.2%
% from 52W Low	20.7%	145.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.45x
FCF Yield (TTM)	-14.7%	-9.0%
Earnings Yield (TTM)	-20.9%	-16.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-325.5
EV/GP/RG	N/A	N/A
Ticker research	View EXOZ research	View HRGN research